Accepted manuscript
Dose-Escalation Study of Amygdalar Transcranial Focused Ultrasound in Healthy Volunteers
Neuromodulation (Malden, Mass.)
Apr 2026
Featured in Collection : Drexel's Newest Publications
Abstract
Transcranial focused ultrasound (tFUS) is a promising noninvasive technique for modulating deep brain structures, but the optimal and safe intensity range for neuromodulation remains unclear. Current FDA intensity limits, designed for diagnostic use rather than therapy, may limit the potential effectiveness of tFUS.
This study aimed to evaluate the safety and preliminary efficacy of escalating tFUS intensities targeting the right amygdala in healthy volunteers, including intensity levels exceeding current FDA diagnostic ultrasound limits.
Ten healthy adults (mean age = 19.5 ± 1.4 years; 70% female) participated in a within-subject, repeated-measures design. Each received four randomized tFUS stimulation conditions (ISPTA.3 = 0.72–10.08 W/cm2) using the BX Pulsar 1002 system. Structural MRI was performed before each stimulation to monitor for safety. Affective modulation was assessed pre- and post-stimulation via the International Affective Picture Set (IAPS) task, measuring changes in valence and arousal ratings. Acoustic modeling was conducted to estimate intracranial energy deposition.
No adverse events or MRI-detectable structural changes (e.g., edema, hemorrhage, or microstructural abnormalities) occurred under any stimulation condition. Behavioral analyses revealed no significant overall effects of intensity in response to affective stimuli. Comparisons between high and low duty cycle paradigms showed no significant differences.
tFUS of the right amygdala at intensities up to 10.08 W/cm2 derated spatial-peak temporal-average intensity (ISPTA.3), an FDA-recognized metric used to estimate ultrasound intensity at the target, substantially exceeding the FDA diagnostic limit, was well tolerated and produced no structural or subjective adverse effects. These findings support the safety of higher-intensity tFUS and justify further investigation in larger and clinical populations to explore potential dose–response effects on emotion regulation.
Metrics
1 Record Views
Details
- Title
- Dose-Escalation Study of Amygdalar Transcranial Focused Ultrasound in Healthy Volunteers
- Creators
- Norman M. Spivak (Corresponding Author) - University of California, Los AngelesAndrew A.E.D. Bishay - University of California, Los AngelesJonathan Haroon - University of California, Los AngelesAmber R. Hopkins - University of California, Los AngelesJody Tanabe - University of Colorado Anschutz Medical CampusSabrina Halavi - University of California, Los AngelesBianca Hoang-Dang - University of California, Los AngelesAndrew J. Swenson - University of California, Los AngelesSamantha F. Schafer - Drexel UniversityMark E. Schafer - Drexel UniversityAlexander Bystritsky - University of California, Los AngelesSusan Y. Bookheimer - University of California, Los AngelesMartin M. Monti - University of California, Los Angeles
- Publication Details
- Neuromodulation (Malden, Mass.)
- Publisher
- Elsevier Inc
- Resource Type
- Accepted manuscript
- Language
- English
- Academic Unit
- School of Biomedical Engineering, Science, and Health Systems
- Other Identifier
- 991022173649904721